
Emily M. Le
Examiner (ID: 5908)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1734, 1793 |
| Total Applications | 433 |
| Issued Applications | 74 |
| Pending Applications | 96 |
| Abandoned Applications | 266 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5776685
[patent_doc_number] => 20060105325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Adsorbent with enhanced protein binding capacity and selectivity'
[patent_app_type] => utility
[patent_app_number] => 11/273562
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7433
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105325.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273562 | Adsorbent with enhanced protein binding capacity and selectivity | Nov 13, 2005 | Abandoned |
Array
(
[id] => 5171766
[patent_doc_number] => 20070072198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes'
[patent_app_type] => utility
[patent_app_number] => 11/270805
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 8790
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072198.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270805 | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes | Nov 8, 2005 | Issued |
Array
(
[id] => 5743208
[patent_doc_number] => 20060088933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Reagents for detecting efavirenz'
[patent_app_type] => utility
[patent_app_number] => 11/255536
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6561
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255536
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255536 | Reagents for detecting efavirenz | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5710400
[patent_doc_number] => 20060051745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'HCV non-structural protein mutants and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/213326
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 21707
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051745.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213326
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213326 | HCV non-structural protein mutants and uses thereof | Aug 25, 2005 | Issued |
Array
(
[id] => 4553740
[patent_doc_number] => 07838017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-23
[patent_title] => 'Polyinosinic acid-polycytidylic acid-based adjuvant'
[patent_app_type] => utility
[patent_app_number] => 10/551847
[patent_app_country] => US
[patent_app_date] => 2005-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 15725
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/838/07838017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551847 | Polyinosinic acid-polycytidylic acid-based adjuvant | Jun 7, 2005 | Issued |
Array
(
[id] => 5888626
[patent_doc_number] => 20060275777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Novel strategies for protein vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/144172
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13144
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11144172
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/144172 | Novel strategies for protein vaccines | Jun 2, 2005 | Abandoned |
Array
(
[id] => 6952234
[patent_doc_number] => 20050227328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/129762
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 185817
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129762 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 12, 2005 | Abandoned |
Array
(
[id] => 5770530
[patent_doc_number] => 20050266461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/124327
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34241
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124327 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 5, 2005 | Abandoned |
| 11/090828 | Immunostimulatory nucleic acids | Mar 24, 2005 | Abandoned |
Array
(
[id] => 5178077
[patent_doc_number] => 20070179137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/594080
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12059
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179137.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594080 | Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives | Mar 23, 2005 | Abandoned |
Array
(
[id] => 170192
[patent_doc_number] => 07662548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Method of screening for modulators of HIV infection'
[patent_app_type] => utility
[patent_app_number] => 11/068686
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14274
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662548.pdf
[firstpage_image] =>[orig_patent_app_number] => 11068686
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/068686 | Method of screening for modulators of HIV infection | Feb 27, 2005 | Issued |
Array
(
[id] => 6926480
[patent_doc_number] => 20050239736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Immunomodulatory oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/067516
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11224
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239736.pdf
[firstpage_image] =>[orig_patent_app_number] => 11067516
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/067516 | Immunomodulatory oligonucleotides | Feb 24, 2005 | Abandoned |
Array
(
[id] => 7019333
[patent_doc_number] => 20050221352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/042449
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34221
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11042449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/042449 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jan 23, 2005 | Abandoned |
Array
(
[id] => 7169686
[patent_doc_number] => 20050202475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/038328
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34234
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11038328
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/038328 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jan 17, 2005 | Abandoned |
Array
(
[id] => 102157
[patent_doc_number] => 07723022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Immunostimulatory nucleic acid molecules'
[patent_app_type] => utility
[patent_app_number] => 11/036527
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21723
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11036527
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/036527 | Immunostimulatory nucleic acid molecules | Jan 13, 2005 | Issued |
Array
(
[id] => 7039279
[patent_doc_number] => 20050158713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Fitness assay and associated methods'
[patent_app_type] => utility
[patent_app_number] => 11/030632
[patent_app_country] => US
[patent_app_date] => 2005-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23176
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030632
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030632 | Fitness assay and associated methods | Jan 5, 2005 | Abandoned |
Array
(
[id] => 6938526
[patent_doc_number] => 20050112089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same'
[patent_app_type] => utility
[patent_app_number] => 11/027967
[patent_app_country] => US
[patent_app_date] => 2005-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6629
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112089.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027967 | Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same | Jan 2, 2005 | Abandoned |
Array
(
[id] => 7039278
[patent_doc_number] => 20050158712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Methods for purifying viral particles for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/016560
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10624
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158712.pdf
[firstpage_image] =>[orig_patent_app_number] => 11016560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/016560 | Methods for purifying viral particles for gene therapy | Dec 16, 2004 | Abandoned |
Array
(
[id] => 428510
[patent_doc_number] => 07267943
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-09-11
[patent_title] => 'Methods for detecting bacteriophage MS2'
[patent_app_type] => utility
[patent_app_number] => 11/009852
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7356
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/267/07267943.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009852 | Methods for detecting bacteriophage MS2 | Dec 1, 2004 | Issued |
Array
(
[id] => 432151
[patent_doc_number] => 07264924
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-09-04
[patent_title] => 'Methods for detecting bacteriophage MS2'
[patent_app_type] => utility
[patent_app_number] => 11/010700
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7356
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/264/07264924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11010700
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/010700 | Methods for detecting bacteriophage MS2 | Dec 1, 2004 | Issued |